TAM
KRSA

Tiverton Asset Management’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Tiverton Asset Management’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$51K Hold
30
– – ﹤0.01% 689
2019
Q2 		$48K Buy
+30
New +$59.4K ﹤0.01% 666

Other funds holding KRSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Slate Path Capital
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Tiverton Asset Management's KRSA Position: Q3 2019 in Review

Tiverton Asset Management held its Korsana Biosciences, Inc. Common Stock (KRSA) position steady in Q3 2019 at 30 shares worth $51K. The position accounts for ﹤0.01% of the portfolio, ranked #689.

Tiverton Asset Management first reported a position in KRSA in Q2 2019 and has held it in 2 quarters since. 86 funds tracked by Wall St. Rank hold KRSA as of Q3 2019.

  • Tiverton Asset Management held 30 shares of Korsana Biosciences, Inc. Common Stock worth $51K as of Q3 2019.
  • Tiverton Asset Management left its Korsana Biosciences, Inc. Common Stock share count unchanged in Q3 2019.
  • Korsana Biosciences, Inc. Common Stock made up ﹤0.01% of Tiverton Asset Management's portfolio in Q3 2019, its #689 holding.
  • Tiverton Asset Management first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and has held it in 2 quarters since.
  • 86 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.